Meriva® is a unique, patented curcumin product. Curcumin is a potent antioxidant flavonoid that offers numerous health benefits, including supporting joint health, and hepatic, GI, and cardiovascular function.
Whether taken as a supplement or from food, curcumin is generally poorly absorbed into the bloodstream. Meriva curcumin phytosome is a unique curcumin extract that is significantly better absorbed than other curcumin extracts. Phytosomes are plant extracts bound to phosphatidylcholine (PC), an essential component of human cells. When taken orally, PC is very well absorbed and curcumin can be bound to PC to enhance its absorption.
A human study demonstrated 29-times greater bioavailability than ordinary curcumin. Meriva supplementation resulted in higher plasma concentrations of curcumin from a much smaller dose than with ordinary curcumin.
Recommended Use or Purpose:
Antioxidant for the maintenance of good health.
Recommended Dose (Adults):
Take 1-2 capsules two times daily or as recommended by your health professional. Consult a health professional for use beyond 3 months.
Curcuminoids-Phosphatidylcholine complex 150 mg
(Curcuma longa (root) / Helianthus annuus (sunflower) (seed))
Standardized to 33% curcuminoids
Non-Medicinal Ingredients: High and low viscosity hydroxypropyl methylcellulose (Time-Sorb), L-Leucine, Calcium Laurate, Calcium Citrate, Hypromellose (derived from cellulose) capsule, Silicon Dioxide, Microcrystalline Cellulose.
Risk Information: Do not use if you have a bile duct obstruction or if you are pregnant or breastfeeding. Consult your health professional prior to use if you have excess stomach acid, or if you have stomach ulcers or gallstones, or if you are taking antiplatelet medication or blood thinners.
Keep out of reach of children. Do not use if security seal inside the cap is broken. Store tightly sealed in a cool, dry place.
This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.
Curcumin has been shown to reduce the therapeutic efficacy of cyclophosphamide (Cytoxan) in animal studies. In vitro research revealed that curcumin decreased camptothecin-induced death of cultured breast cancer cells. Curcumin might also interfere with the absorption and efficacy of the chemotherapy drug irinotecan, used to treat colon cancer. The concurrent use of curcumin with these agents should be avoided.